Successful Strategies to Recruit Patients with Familial Mediterranean Fever for a Multicenter Clinical Trial-Reference-Cited by-同舟云学术

Successful Strategies to Recruit Patients with Familial Mediterranean Fever for a Multicenter Clinical Trial

Published:2021-01-31 Issue:1 Volume:52 Page:3-7
ISSN:0388-1601
Container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
language:en
Short-container-title:Jpn. J. Clin. Pharmacol. Ther.

Author:

HAGIMORI Naoko¹²,KOGA Tomohiro³⁴⁵,TAKEMORI Sachiko¹,HOSOGAYA Naoki¹,FUKUSHIMA Chizu¹,YAMAMOTO Hiroshi¹,KAWAKAMI Atsushi²,the FMF Project Team

Affiliation:

1. Nagasaki University Hospital Clinical Research Center, Japan

2. Translational Research Center for Medical Innovation at Kobe, Japan

3. Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Japan

4. Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan

5. Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan

Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical),Pharmacology

Link

https://www.jstage.jst.go.jp/article/jscpt/52/1/52_3/_pdf

Reference20 articles.

1. 1) Koga T, Sato S, Miyamoto J, Hagimori N, Kawazoe Y, Arinaga K, et al. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial. Trials. 2018; 19 (1): 715‒23. doi: 10.1186/s13063‒018‒3105‒6.

2. 2) Goldstein RC, Schwabe AD. Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med. 1974; 81 (6): 792‒4. doi: 10.7326/0003‒4819‒81‒6‒792.

3. 3) Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol. 2011; 31 (6): 968‒76. doi: 10.1007/s10875‒011‒9594‒7.

4. 4) Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997; 40 (10): 1879‒85. doi: 10.1002/art.1780401023.

5. 5) Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016; 75 (4): 644‒51. doi: 10.1136/annrheumdis‒2015‒208690.